BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 29534696)

  • 1. Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies.
    Qiao Y; Yang T; Gan Y; Li W; Wang C; Gong Y; Lu Z
    BMC Cancer; 2018 Mar; 18(1):288. PubMed ID: 29534696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin and cancer risk: an updated quantitative review to 2005.
    Bosetti C; Gallus S; La Vecchia C
    Cancer Causes Control; 2006 Sep; 17(7):871-88. PubMed ID: 16841255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis.
    González-Pérez A; García Rodríguez LA; López-Ridaura R
    BMC Cancer; 2003 Oct; 3():28. PubMed ID: 14588079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin use and the risk of prostate cancer: a meta-analysis of 24 epidemiologic studies.
    Huang TB; Yan Y; Guo ZF; Zhang XL; Liu H; Geng J; Yao XD; Zheng JH
    Int Urol Nephrol; 2014 Sep; 46(9):1715-28. PubMed ID: 24687637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin and the risk of nondigestive tract cancers: An updated meta-analysis to 2019.
    Santucci C; Gallus S; Martinetti M; La Vecchia C; Bosetti C
    Int J Cancer; 2021 Mar; 148(6):1372-1382. PubMed ID: 32984948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis.
    Lin JL; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Huang CM
    BMC Cancer; 2020 Jul; 20(1):638. PubMed ID: 32646396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence.
    Jacobs EJ; Thun MJ; Bain EB; Rodriguez C; Henley SJ; Calle EE
    J Natl Cancer Inst; 2007 Apr; 99(8):608-15. PubMed ID: 17440162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin Use and Risk of Breast Cancer: A Meta-analysis of Observational Studies from 1989 to 2019.
    Ma S; Guo C; Sun C; Han T; Zhang H; Qu G; Jiang Y; Zhou Q; Sun Y
    Clin Breast Cancer; 2021 Dec; 21(6):552-565. PubMed ID: 33741292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin might reduce the incidence of breast cancer: An updated meta-analysis of 38 observational studies.
    Cao Y; Tan A
    Medicine (Baltimore); 2020 Sep; 99(38):e21917. PubMed ID: 32957311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsteroidal anti-inflammatory drugs and risk of ovarian cancer: systematic review and meta-analysis of observational studies.
    Baandrup L; Faber MT; Christensen J; Jensen A; Andersen KK; Friis S; Kjaer SK
    Acta Obstet Gynecol Scand; 2013 Mar; 92(3):245-55. PubMed ID: 23240575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin and cancer risk: a quantitative review to 2011.
    Bosetti C; Rosato V; Gallus S; Cuzick J; La Vecchia C
    Ann Oncol; 2012 Jun; 23(6):1403-15. PubMed ID: 22517822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin use and risk of breast cancer: systematic review and meta-analysis of observational studies.
    Zhong S; Chen L; Zhang X; Yu D; Tang J; Zhao J
    Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1645-55. PubMed ID: 26315555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Efficacy of Aspirin in Preventing the Recurrence of Colorectal Adenoma: a Renewed Meta-Analysis of Randomized Trials.
    Zhao TY; Tu J; Wang Y; Cheng DW; Gao XK; Luo H; Yan BC; Xu XL; Zhang HL; Lu XJ; Wang YJ
    Asian Pac J Cancer Prev; 2016; 17(5):2711-7. PubMed ID: 27268656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin use and lung cancer risk: a possible relationship? Evidence from an updated meta-analysis.
    Jiang HY; Huang TB; Xu L; Yu J; Wu Y; Geng J; Yao XD
    PLoS One; 2015; 10(4):e0122962. PubMed ID: 25849465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of aspirin use and risk of lung cancer shows notable results.
    Hochmuth F; Jochem M; Schlattmann P
    Eur J Cancer Prev; 2016 Jul; 25(4):259-68. PubMed ID: 26067033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin and the risk of colorectal and other digestive tract cancers: an updated meta-analysis through 2019.
    Bosetti C; Santucci C; Gallus S; Martinetti M; La Vecchia C
    Ann Oncol; 2020 May; 31(5):558-568. PubMed ID: 32272209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin and cancer risk: an update to 2001.
    Bosetti C; Gallus S; La Vecchia C
    Eur J Cancer Prev; 2002 Dec; 11(6):535-42. PubMed ID: 12457105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin and non-steroidal anti-inflammatory drugs use reduce gastric cancer risk: A dose-response meta-analysis.
    Huang XZ; Chen Y; Wu J; Zhang X; Wu CC; Zhang CY; Sun SS; Chen WJ
    Oncotarget; 2017 Jan; 8(3):4781-4795. PubMed ID: 27902474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin and nonsteroidal anti-inflammatory drug use and risk of pancreatic cancer: a meta-analysis.
    Larsson SC; Giovannucci E; Bergkvist L; Wolk A
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2561-4. PubMed ID: 17164387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials.
    Algra AM; Rothwell PM
    Lancet Oncol; 2012 May; 13(5):518-27. PubMed ID: 22440112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.